US market to dent India pharma earnings even as domestic growth remains firm
New Delhi: India’s pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of FY26, according to a report by…
Delhi HC quashes government ban on FDC drugs
New Delhi: In a major relief to the pharmaceutical sector, the Delhi high court on Thursday quashed a government-imposed ban on fixed dose combination (FDC) drugs. The cases—filed by several…








